Silverback Therapeutics Funding: $210M Raised, Series C
Silverback Therapeutics is based in Seattle, WA. It has raised $210M in total funding. Latest round: Series C.
Silverback Therapeutics funding overview
Silverback Therapeutics is based in Seattle, WA. Silverback Therapeutics has raised $210M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2020. The round record for Silverback Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include EcoR1 Capital, RA Capital, OrbiMed Advisors, U.S. Venture Partners, Boxer Capital, Fidelity Management & Research Company LLC and 4 others. 10 distinct backers are named across the disclosed rounds.
Silverback Therapeutics at a glance
Total raised
$210M
Latest round
Series C
Latest round date
September 2020
Headquarters
Seattle, WA
Notable investors
EcoR1 Capital, RA Capital, OrbiMed Advisors, U.S. Venture Partners, Boxer Capital, Fidelity Management & Research Company LLC, Nantahala Capital Management, Nextech Invest Ltd.
Frequently asked about Silverback Therapeutics funding
How much has Silverback Therapeutics raised?
Silverback Therapeutics has raised $210M in total disclosed funding across the rounds on record.
Who has invested in Silverback Therapeutics?
EcoR1 Capital, RA Capital, OrbiMed Advisors, U.S. Venture Partners, Boxer Capital, Fidelity Management & Research Company LLC are named among the investors backing Silverback Therapeutics.
What was the latest Silverback Therapeutics funding round?
The most recent disclosed round is a Series C, announced in September 2020.
Where is Silverback Therapeutics based?
Silverback Therapeutics is based in Seattle, WA.
When did Silverback Therapeutics last raise?
The last disclosed Silverback Therapeutics round closed in September 2020 at Series C.
Totals shown for Silverback Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
